Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

References

• Brunner PM, Silverberg JI, Guttman-Yassky E, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137(1):18–25.
   PubMed Web of Science ®Google Scholar
• Thijs JL, Strickland I, Bruijnzeel-Koomen C, et al. Serum biomarker profiles suggest that atopic dermatitis is a systemic disease. J Allergy Clin Immunol. 2018;141(4):1523–1526.
   PubMed Web of Science ®Google Scholar
• Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22(2):125–137.
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233–246.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis–part I: clinical and pathologic concepts. J Allergy Clin Immunol. 2011;127(5):1110–1118.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Guttman-Yassky E, Margolis DJ, et al. Association of inadequately controlled disease and disease severity with patient-reported disease burden in adults with atopic dermatitis. JAMA Dermatol. 2018;154(8):903–912.
   PubMed Web of Science ®Google Scholar
• Chalmers JR, Thomas KS, Apfelbacher C, et al. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol. 2018;178(5):e332–e341.
   PubMed Web of Science ®Google Scholar
• Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67(9):1111–1117.
   PubMed Web of Science ®Google Scholar
• Leung DY, Guttman-Yassky E. Assessing the current treatment of atopic dermatitis: Unmet needs. J Allergy Clin Immunol. 2017;139(4):S47–S48.
   PubMed Web of Science ®Google Scholar
• European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23–31.
   PubMed Web of Science ®Google Scholar
• Tofte S, Graeber M, Cherill R, et al. Eczema area and severity index (EASI): a new tool to evaluate atopic dermatitis. J Eur Acad Dermatol Venereol. 1998;11:S197.
   Google Scholar
• Siegfried E, Korman N, Molina C, et al. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis. J Dermatolog Treat. 2006;17(3):143–150.
   PubMed Web of Science ®Google Scholar
• Rehal B, Armstrong AW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS One. 2011;6(4):e17520.
   PubMed Web of Science ®Google Scholar
• Simpson E, Beck LA, Wu R, et al. Correlation between clinical and patient-reported outcomes in patients with moderate-to-severe atopic dermatitis in a phase 2 clinical trial of dupilumab. Poster Presented at the 23rd World Congress of Dermatology; Vancouver (BC). 2015, p. 8–13.
   Google Scholar
• Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol. 2007;120(6):1389–1398.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Eckert L, Chen Z, et al. P480 Correlations of itch with quality of life and signs of atopic dermatitis across dupilumab trials. Ann Allergy Asthma Immunol. 2017;119(5):S95.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Reaney M, Mastey V, et al. Peak pruritus numerical rating scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis. Br J Dermatol. 2019;181:761–769.
   PubMed Web of Science ®Google Scholar
• Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol. 2004;140(12):1513–1519.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims 2009. [cited 2018 September 14].
   Google Scholar
• Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–351.
   PubMed Web of Science ®Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77–101.
   Google Scholar
• Frost MH, Reeve BB, Liepa AM, et al. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. 2007;10(Suppl 2):S94–S105.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Sahay AP, et al. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105–110.
   PubMed Web of Science ®Google Scholar
• Cohen J. A power primer. Psych Bull. 1992;112(1):155–159.
   PubMed Web of Science ®Google Scholar
• Langan SM, Schmitt J, Williams HC, et al. How are eczema “flares” defined? A systematic review and recommendation for future studies. Br J Dermatol. 2014;170(3):548–556.
   PubMed Web of Science ®Google Scholar
• Langan SM, Stuart B, Bradshaw L, et al. Measuring long-term disease control in patients with atopic dermatitis: A validation study of well-controlled weeks. J Allergy Clin Immunol. 2017;140(6):1580–1586.
   PubMed Web of Science ®Google Scholar
• Howells LM, Chalmers JR, Cowdell F, et al. When it goes back to my normal I suppose’: a qualitative study using online focus groups to explore perceptions of “control” among people with eczema and parents of children with eczema in the UK. BMJ Open. 2017;15:11.
   Google Scholar
• Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2-Assessing Respondent Understanding. Value Health. 2011;14(8):978–988.
   PubMed Web of Science ®Google Scholar
• Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res. 2008;8(1):137–152.
   Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
   Web of Science ®Google Scholar
• Coon CD, Cook KF. Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores. Qual Life Res. 2018;27(1):33–40.
   PubMed Web of Science ®Google Scholar
• Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. New York (NY): Oxford University Press; 1995.
   Google Scholar
• Wei W, Anderson P, Gadkari A, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825–835.
   PubMed Web of Science ®Google Scholar
• Simpson E, Eckert L, Gadkari A, et al. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. BMC Dermatol. 2019;19(1):15.
   PubMed Web of Science ®Google Scholar
• Harmonising Outcome Measures for Eczema (HOME) [Internet]. Core Outcome Set (COS) and core outcome instruments (for clinical trials). 2019 [cited 2019 November 8]. Available from: http://www.homeforeczema.org/index.aspx.
   Google Scholar
• Ridd MJ, King AJL, Le Roux E, et al. Systematic review of self-management interventions for people with eczema. Br J Dermatol. 2017;177(3):719–734.
   PubMed Web of Science ®Google Scholar
• Department of Health. A mandate from the Government to NHS England: April 2014 to March 2015. 2015 [cited 2017 June 29]. Available from: https://www.gov.uk/government/publications/nhs-mandate-2014-to-2015.
   Google Scholar
• Olde Rikkert MGM, van der Wees PJ, Schoon Y, et al. Using patient reported outcomes measures to promote integrated care. Int J Integr Care. 2018;18(2):8.
   PubMed Web of Science ®Google Scholar
• Small M, Vickers A, Anderson P, et al. The patient-physician partnership in asthma: real-world observations associated with clinical and patient-reported outcomes. Adv Therapy. 2010;27(9):591–599.
   PubMed Web of Science ®Google Scholar
• Hamdy FC, Donovan JL. Patient-reported outcomes following treatment for localized prostate cancer: Helping decision making for patients and their physicians. JAMA. 2017;317(11):1121–1123.
   PubMed Web of Science ®Google Scholar
• Calvert M, Kyte D, Price G, et al. Maximising the impact of patient reported outcome assessment for patients and society. BMJ. 2019;364:k5267.
   PubMed Web of Science ®Google Scholar